All Updates

All Updates

icon
Filter
Product updates
Matterworks launches AI-powered platform Pyxis for quantifying untargeted analytes
AI Drug Discovery
Jun 3, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Jun 20, 2024
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Jun 20, 2024
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Jun 20, 2024
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Jun 20, 2024
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Jun 20, 2024
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Jun 20, 2024
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Jun 20, 2024
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Jun 20, 2024
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Jun 20, 2024
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Jun 20, 2024
AI Drug Discovery

AI Drug Discovery

Jun 3, 2024

Matterworks launches AI-powered platform Pyxis for quantifying untargeted analytes

Product updates

  • AI-based life sciences discovery and development company Matterworks has introduced its new AI-driven platform, Pyxis, designed to simplify and enhance the quantification of "analytes," which are chemical substances related to the analytical stage of a drug's discovery process.

  • According to the company, the platform can standardize the whole quantitation process of untargeted analytes, which is typically a complex procedure. It eliminates the need for per-analyte calibration, peak selection, integration, and manual data analysis, and enables direct conversion of raw LC-MS data into a list of detected metabolites with their respective concentrations, which is biologically actionable. 

  • Matterworks develops advanced AI platforms for modeling real-time biology, accelerating the discovery, development, and manufacturing of life sciences technologies. The company's key offering is Pyxis, an ML software that revolutionizes metabolomics workflows by compressing weeks of traditional data acquisition and interpretation into real-time insight generation.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.